Pai, Manjunath P.; Cojutti, Pier Giorgio; De Paola, Riccardo; Zamparini, Eleonora; Tedeschi, Sara; Giuliano, Simone; Meschiari, Marianna; Prezzavento, Alessia; Zammarchi, Lorenzo; Viale, Pierluigi; Pea, Federico, Optimizing dalbavancin dosing for complicated MRSA infections: a multicenter population pharmacokinetic study, «CLINICAL MICROBIOLOGY AND INFECTION», 2026, https://doi.org/10.1016/j.cmi.2026.05.049, pp. 1 - 24 [Scientific article]
Cojutti, Pier Giorgio; Pascale, Renato; Grechi, Andrea; Ambretti, Simone; Viale, Pierluigi; Pea, Federico, Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction?, «ANTIBIOTICS», 2026, 15, Article number: 315 , pp. 1 - 15 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directions, «EXPERT OPINION ON PHARMACOTHERAPY», 2026, 10.1080/14656566.2026.2651279, pp. 1 - 19 [Scientific article]
Gatti, Milo; Pea, Federico, Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?, «INFECTIOUS DISEASE REPORTS», 2026, 18, Article number: 3 , pp. 1 - 4 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Re: ‘Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis’ by Chiriac et al, «CLINICAL MICROBIOLOGY AND INFECTION», 2026, 10.1016/j.cmi.2026.05.006, pp. 1 - 2 [Comment or similar]
Gatti, Milo; Pea, Federico, Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations, «INFECTION AND DRUG RESISTANCE», 2026, 19, pp. 1 - 23 [Scientific article]Open Access
Liu, Chun; Cojutti, Pier Giorgio; Van Hasselt, J. G. Coen; Bartoletti, Michele; Giannella, Maddalena; Zinzani, Pierluigi; Viale, Pierluigi; Pea, Federico, Relationship between continuous infusion meropenem PK/PD target attainment and C‐reactive protein dynamics in onco‐haematologic patients with febrile neutropenia, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2026, Online First, pp. 1 - 10 [Scientific article]Open Access
Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion, «PHARMACEUTICS», 2026, 18, Article number: 91 , pp. 1 - 20 [Scientific article]Open Access
Di Bella, Stefano; Geremia, Nicholas; Pea, Federico; Zeitlinger, Markus; Sanson, Gianfranco; Monticelli, Jacopo; Bergmann, Felix; Motet, Christian; Lambotte-Buffet, Christophe; Zerbato, Verena; Gatti, Milo, When and How to Use Subcutaneous Antibiotics, «CLINICAL INFECTIOUS DISEASES», 2026, 82, pp. 662 - 673 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, pp. 1 - 12 [Scientific article]Open Access
Gatti, M.; Rinaldi, M.; Bonazzetti, C.; Siniscalchi, A.; Tonetti, T.; Ambretti, S.; Giannella, M.; Viale, P.; Pea, F., A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar?, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1543 - 1551 [Scientific article]Open Access
Cheng, Lucy; Kumar, Suchita; Cojutti, Pier Giorgio; Pea, Federico; Tang Girdwood, Sonya; Morales Junior, Ronaldo, Can a population pharmacokinetics model built on intermittent infusions accurately predict meropenem concentrations in children receiving continuous infusions?, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2025, 10.1002/bcp.70376, pp. 1 - 6 [Scientific article]
Cojutti, Pier Giorgio; Tedeschi, Sara; Zamparini, Eleonora; Fornaro, Giacomo; Zagarrigo, Manuel; De Paolis, Massimiliano; Viale, Pierluigi; Pea, Federico, Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?, «ANTIBIOTICS», 2025, 14, Article number: 139 , pp. 1 - 14 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2025, N/A, pp. 1 - 37 [Scientific article]Open Access
Bhakta, Sanjib; Xie, Jianping; Pea, Federico; Gillespie, Stephen H., Data transparency and reproducibility in health research: bridging the gap for early-career researchers, «FRONTIERS IN ANTIBIOTICS», 2025, 4, Article number: 1562002 , pp. 1 - 6 [Scientific article]Open Access
